-transparent.png){kind=logo}
OBJECTIVE To determine whether urinary beta 2-glycoprotein-1 assays can provide improved discrimination between chronic renal diseases which are primarily of tubular or glomerular origin. METHODS Urinary beta 2-glycoprotein-1, retinol-binding protein, alpha 1-microglobulin, beta 2-microglobulin, N-acetyl-beta-D-glucosa-minidase and albumin were measured in 51 patients with primary glomerular disease, 23 with obstructive nephropathy, and 15 with polycystic kidney disease, and expressed per mmol of creatinine. Plasma beta 2-glycoprotein-1 was assayed in 52 patients and plasma creatinine in all 89. The findings were compared between the diagnostic groups and with previously published data relating to primary tubular disorders. RESULTS All 31 patients with plasma creatinine greater than 200 mumol/l excreted increased amounts of beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin, and 29 had increased N-acetyl-beta-D-glucosaminidase; the quantities were generally similar to those found in comparable patients with primary tubular pathology. Among 58 with plasma creatinine concentrations under 200 mumol/l, increases in beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin excretion were less common and much smaller, especially in those with obstructive nephropathy and polycystic disease. The ratios of the excretion of albumin to the other proteins provided the clearest discrimination between the patients with glomerular or tubular malfunction, but an area of overlap was present which embraced those with obstructive nephropathy and polycystic disease. CONCLUSIONS Increased excretion of beta 2-glycoprotein-1 due to a raised plasma concentration or diminution of tubular reabsorption, or both, is common in all the forms of renal disease investigated, and both plasma creatinine and urinary albumin must be taken into account when interpreting results. Ratios of urinary albumin: beta 2-glycoprotein-1 greater than 1000 are highly suggestive of primary glomerular disease and those less than 40 of primary tubular disease. Used in this way, beta 2-glycoprotein-1 assays provide superior discrimination between glomerular and tubular malfunction when compared with retinol binding protein but the best discrimination is provided by albumin: alpha 1-microglobulin ratios.
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
August 1992,
Human biology,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
May 2004,
Gastroenterologia y hepatologia,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
January 2013,
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
March 2018,
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
April 1983,
The Journal of biological chemistry,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
January 1984,
The International journal of biochemistry,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
September 1980,
Investigative urology,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
May 1994,
Biochemical and biophysical research communications,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
September 1992,
The Journal of rheumatology,
F V Flynn, and
M Lapsley, and
P A Sansom, and
S L Cohen
July 1997,
Human genetics,
